Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

699 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.
Gault N, Esposito-Farèse M, Revest M, Inamo J, Cabié A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, De Montmollin E, Oziol E, Etienne M, Laouénan C, Rossignol P, Costagliola D, Vidal-Petiot E; French-Covid cohort investigators, study group. Gault N, et al. Among authors: rossignol p. Fundam Clin Pharmacol. 2021 Dec;35(6):1141-1158. doi: 10.1111/fcp.12683. Epub 2021 May 16. Fundam Clin Pharmacol. 2021. PMID: 33876439 Free PMC article.
Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries.
Rossignol P, Zannad F, Pitt B; Writing group of 10th Global Cardio Vascular Clinical Trialist forum held on December 6th-7th 2013 in Paris, France. Rossignol P, et al. Int J Cardiol. 2014 Dec 20;177(3):731-3. doi: 10.1016/j.ijcard.2014.11.004. Epub 2014 Nov 5. Int J Cardiol. 2014. PMID: 25465821 Review.
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
Zannad F, Rossignol P, Stough WG, Epstein M, Alonso Garcia Mde L, Bakris GL, Butler J, Kosiborod M, Berman L, Mebazaa A, Rasmussen HS, Ruilope LM, Stockbridge N, Thompson A, Wittes J, Pitt B. Zannad F, et al. Among authors: rossignol p. Int J Cardiol. 2016 Aug 1;216:46-51. doi: 10.1016/j.ijcard.2016.04.127. Epub 2016 Apr 19. Int J Cardiol. 2016. PMID: 27140336 Review.
Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJ, Damman K. Beldhuis IE, et al. Among authors: rossignol p. Circ Heart Fail. 2017 Feb;10(2):e003588. doi: 10.1161/CIRCHEARTFAILURE.116.003588. Circ Heart Fail. 2017. PMID: 28209765 Review.
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P. Beusekamp JC, et al. Among authors: rossignol p. Eur J Heart Fail. 2018 May;20(5):923-930. doi: 10.1002/ejhf.1079. Epub 2018 Jan 12. Eur J Heart Fail. 2018. PMID: 29327797 Free article.
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P; Collaborators. Levy B, et al. Among authors: rossignol p. J Am Coll Cardiol. 2018 Jul 10;72(2):173-182. doi: 10.1016/j.jacc.2018.04.051. J Am Coll Cardiol. 2018. PMID: 29976291 Free article. Clinical Trial.
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.
Ferreira JP, Couchoud C, Gregson J, Tiple A, Glowacki F, London G, Agarwal R, Rossignol P. Ferreira JP, et al. Among authors: rossignol p. Nephrol Dial Transplant. 2019 Jul 1;34(7):1216-1222. doi: 10.1093/ndt/gfy378. Nephrol Dial Transplant. 2019. PMID: 30590716
Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial).
Legrand M, Futier E, Leone M, Deniau B, Mebazaa A, Plaud B, Coriat P, Rossignol P, Vicaut E, Gayat E; STOP-OR-NOT study investigators. Legrand M, et al. Among authors: rossignol p. Trials. 2019 Mar 5;20(1):160. doi: 10.1186/s13063-019-3247-1. Trials. 2019. PMID: 30836981 Free PMC article.
Emerging Drug Classes and Their Potential Use in Hypertension.
Azizi M, Rossignol P, Hulot JS. Azizi M, et al. Among authors: rossignol p. Hypertension. 2019 Nov;74(5):1075-1083. doi: 10.1161/HYPERTENSIONAHA.119.12676. Epub 2019 Sep 9. Hypertension. 2019. PMID: 31495277 Free article. Review.
Renin-angiotensin-aldosterone system and kidney interactions in heart failure.
Ferreira JP, Rossignol P, Zannad F. Ferreira JP, et al. Among authors: rossignol p. J Renin Angiotensin Aldosterone Syst. 2019 Oct-Dec;20(4):1470320319889415. doi: 10.1177/1470320319889415. J Renin Angiotensin Aldosterone Syst. 2019. PMID: 31739737 Free PMC article. No abstract available.
699 results